Skip to main content

Table 4 Baseline profile and outcome of patients with intervention prior to referral (group B)

From: Comparison of clinico-microbiological profile and treatment outcome of in-house and referred post cataract surgery endophthalmitis in a tertiary care center in South India

S no.

Age (years)

Prior intervention

Presenting BCVA

Our intervention

Organism

Sensitivity

Final BCVA

1

70

IOAB

LP

PPV + 2x IOAB

P. aeroginosa

Sensitive to amikacin, ceftazidime, gatifloxacin, moxifloxacin, cirprofloxacin, and ofloxacin

Resistant to chloramphenicol

LP

2

10

2x IOAB

LP

PPV + 2x IOAB

Streptococcus pyogenes

Sensitive to vanomycin, gatifloxacin, moxifloxacin, cirprofloxacin, and ofloxacin

Resistant to amikacin

 

3

64

AC wash + IOAB

LP

Vitreous biopsy + 5x IOAB

P. aeruginosa

Sensitive to amikacin, ceftazidime, gatifloxacin, moxifloxacin, cirprofloxacin, and ofloxacin

Resistant to tobramycin

LP

4

62

Vitreous biosy + IOAB

6/36

PPV + 2x IOAB

R. radiobacter

Sensitive to amikacin, ceftazidime, gatifloxacin, moxifloxacin, cirprofloxacin, ofloxacin

Resistant to chloramphenicol

6/36

5

55

2x IOAB

6/36

PPV + IOAB + 2x Intravitreal Amphoterecin B

C. pelliculosa

6/15

  1. IOAB intraocular (antibacterial) antibiotic injection